Stressing the vaccine had a "strong safety profile", biotech firm CSL said: "The potential for this cross-reaction had been anticipated prior to the commencement of the trial".
He will be proceeding to Bharat Biotech's facility located at Genome valley, a life sciences cluster about 20 km from the Air Force base, officials said.